-
1
-
-
67649124259
-
Increased accumulation of intraneuronal amyloid beta in HIV-infected patients
-
Achim C.L., Adame A., Dumaop W., Everall I.P., and Masliah E. Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J. Neuroimmune Pharmacol. 4 (2009) 190-199
-
(2009)
J. Neuroimmune Pharmacol.
, vol.4
, pp. 190-199
-
-
Achim, C.L.1
Adame, A.2
Dumaop, W.3
Everall, I.P.4
Masliah, E.5
-
2
-
-
42449095035
-
Simvastatin protects against amyloid beta and HIV-1 Tat-induced promoter activities of inflammatory genes in brain endothelial cells
-
Andras I.E., Rha G., Huang W., Eum S., Couraud P.O., Romero I.A., Hennig B., and Toborek M. Simvastatin protects against amyloid beta and HIV-1 Tat-induced promoter activities of inflammatory genes in brain endothelial cells. Mol. Pharmacol. 73 (2008) 1424-1433
-
(2008)
Mol. Pharmacol.
, vol.73
, pp. 1424-1433
-
-
Andras, I.E.1
Rha, G.2
Huang, W.3
Eum, S.4
Couraud, P.O.5
Romero, I.A.6
Hennig, B.7
Toborek, M.8
-
3
-
-
40449141429
-
Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy
-
Bhaskaran K., Mussini C., Antinori A., Walker A.S., Dorrucci M., Sabin C., Phillips A., and Porter K. Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Ann. Neurol. 63 (2008) 213-221
-
(2008)
Ann. Neurol.
, vol.63
, pp. 213-221
-
-
Bhaskaran, K.1
Mussini, C.2
Antinori, A.3
Walker, A.S.4
Dorrucci, M.5
Sabin, C.6
Phillips, A.7
Porter, K.8
-
4
-
-
0031004788
-
Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells
-
Blanc E.M., Toborek M., Mark R.J., Hennig B., and Mattson M.P. Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J. Neurochem. 68 (1997) 1870-1881
-
(1997)
J. Neurochem.
, vol.68
, pp. 1870-1881
-
-
Blanc, E.M.1
Toborek, M.2
Mark, R.J.3
Hennig, B.4
Mattson, M.P.5
-
5
-
-
67649119686
-
Neurodegeneration and ageing in the HAART era
-
Brew B.J., Crowe S.M., Landay A., Cysique L.A., and Guillemin G. Neurodegeneration and ageing in the HAART era. J. Neuroimmune Pharmacol. 4 (2009) 163-174
-
(2009)
J. Neuroimmune Pharmacol.
, vol.4
, pp. 163-174
-
-
Brew, B.J.1
Crowe, S.M.2
Landay, A.3
Cysique, L.A.4
Guillemin, G.5
-
6
-
-
38349143353
-
RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease
-
Chen X., Walker D.G., Schmidt A.M., Arancio O., Lue L.F., and Yan S.D. RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease. Curr. Mol. Med. 7 (2007) 735-742
-
(2007)
Curr. Mol. Med.
, vol.7
, pp. 735-742
-
-
Chen, X.1
Walker, D.G.2
Schmidt, A.M.3
Arancio, O.4
Lue, L.F.5
Yan, S.D.6
-
7
-
-
33947164189
-
Abeta peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons
-
Clifford P.M., Zarrabi S., Siu G., Kinsler K.J., Kosciuk M.C., Venkataraman V., D'Andrea M.R., Dinsmore S., and Nagele R.G. Abeta peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons. Brain Res. 1142 (2007) 223-236
-
(2007)
Brain Res.
, vol.1142
, pp. 223-236
-
-
Clifford, P.M.1
Zarrabi, S.2
Siu, G.3
Kinsler, K.J.4
Kosciuk, M.C.5
Venkataraman, V.6
D'Andrea, M.R.7
Dinsmore, S.8
Nagele, R.G.9
-
8
-
-
34147183707
-
Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease
-
Deane R., and Zlokovic B.V. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. Curr. Alzheimer Res. 4 (2007) 191-197
-
(2007)
Curr. Alzheimer Res.
, vol.4
, pp. 191-197
-
-
Deane, R.1
Zlokovic, B.V.2
-
9
-
-
0037703255
-
RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain
-
Deane R., Du Yan S., Submamaryan R.K., LaRue B., Jovanovic S., Hogg E., Welch D., Manness L., Lin C., Yu J., Zhu H., Ghiso J., Frangione B., Stern A., Schmidt A.M., Armstrong D.L., Arnold B., Liliensiek B., Nawroth P., Hofman F., Kindy M., Stern D., and Zlokovic B. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 9 (2003) 907-913
-
(2003)
Nat. Med.
, vol.9
, pp. 907-913
-
-
Deane, R.1
Du Yan, S.2
Submamaryan, R.K.3
LaRue, B.4
Jovanovic, S.5
Hogg, E.6
Welch, D.7
Manness, L.8
Lin, C.9
Yu, J.10
Zhu, H.11
Ghiso, J.12
Frangione, B.13
Stern, A.14
Schmidt, A.M.15
Armstrong, D.L.16
Arnold, B.17
Liliensiek, B.18
Nawroth, P.19
Hofman, F.20
Kindy, M.21
Stern, D.22
Zlokovic, B.23
more..
-
10
-
-
7644225312
-
RAGE (yin) versus LRP (yang) balance regulates Alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier
-
Deane R., Wu Z., and Zlokovic B.V. RAGE (yin) versus LRP (yang) balance regulates Alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier. Stroke 35 (2004) 2628-2631
-
(2004)
Stroke
, vol.35
, pp. 2628-2631
-
-
Deane, R.1
Wu, Z.2
Zlokovic, B.V.3
-
11
-
-
33749157416
-
RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease
-
Donahue J.E., Flaherty S.L., Johanson C.E., Duncan III J.A., Silverberg G.D., Miller M.C., Tavares R., Yang W., Wu Q., Sabo E., Hovanesian V., and Stopa E.G. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathol. 112 (2006) 405-415
-
(2006)
Acta Neuropathol.
, vol.112
, pp. 405-415
-
-
Donahue, J.E.1
Flaherty, S.L.2
Johanson, C.E.3
Duncan III, J.A.4
Silverberg, G.D.5
Miller, M.C.6
Tavares, R.7
Yang, W.8
Wu, Q.9
Sabo, E.10
Hovanesian, V.11
Stopa, E.G.12
-
13
-
-
32944456977
-
Statins could be used to control replication of some viruses, including HIV-1
-
Gilbert C., Bergeron M., Methot S., Giguere J.F., and Tremblay M.J. Statins could be used to control replication of some viruses, including HIV-1. Viral Immunol. 18 (2005) 474-489
-
(2005)
Viral Immunol.
, vol.18
, pp. 474-489
-
-
Gilbert, C.1
Bergeron, M.2
Methot, S.3
Giguere, J.F.4
Tremblay, M.J.5
-
14
-
-
0030738647
-
Accumulation of beta-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities
-
Giometto B., An S.F., Groves M., Scaravilli T., Geddes J.F., Miller R., Tavolato B., Beckett A.A., and Scaravilli F. Accumulation of beta-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities. Ann. Neurol. 42 (1997) 34-40
-
(1997)
Ann. Neurol.
, vol.42
, pp. 34-40
-
-
Giometto, B.1
An, S.F.2
Groves, M.3
Scaravilli, T.4
Geddes, J.F.5
Miller, R.6
Tavolato, B.7
Beckett, A.A.8
Scaravilli, F.9
-
15
-
-
15944397586
-
Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients
-
Green D.A., Masliah E., Vinters H.V., Beizai P., Moore D.J., and Achim C.L. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 19 (2005) 407-411
-
(2005)
AIDS
, vol.19
, pp. 407-411
-
-
Green, D.A.1
Masliah, E.2
Vinters, H.V.3
Beizai, P.4
Moore, D.J.5
Achim, C.L.6
-
16
-
-
33846639179
-
Statins and the vascular endothelial inflammatory response
-
Greenwood J., and Mason J.C. Statins and the vascular endothelial inflammatory response. Trends Immunol. 28 (2007) 88-98
-
(2007)
Trends Immunol.
, vol.28
, pp. 88-98
-
-
Greenwood, J.1
Mason, J.C.2
-
17
-
-
65549114145
-
Peripherally expressed neprilysin reduces brain amyloid burden: a novel approach for treating Alzheimer's disease
-
Guan H., Liu Y., Daily A., Police S., Kim M.H., Oddo S., LaFerla F.M., Pauly J.R., Murphy M.P., and Hersh L.B. Peripherally expressed neprilysin reduces brain amyloid burden: a novel approach for treating Alzheimer's disease. J. Neurosci. Res. 87 (2009) 1462-1473
-
(2009)
J. Neurosci. Res.
, vol.87
, pp. 1462-1473
-
-
Guan, H.1
Liu, Y.2
Daily, A.3
Police, S.4
Kim, M.H.5
Oddo, S.6
LaFerla, F.M.7
Pauly, J.R.8
Murphy, M.P.9
Hersh, L.B.10
-
18
-
-
33749498028
-
Effect of nelfinavir on insulin metabolism, proteasome activity and protein degradation in HepG2 cells
-
Hamel F.G., Fawcett J., Tsui B.T., Bennett R.G., and Duckworth W.C. Effect of nelfinavir on insulin metabolism, proteasome activity and protein degradation in HepG2 cells. Diabetes Obes. Metab. 8 (2006) 661-668
-
(2006)
Diabetes Obes. Metab.
, vol.8
, pp. 661-668
-
-
Hamel, F.G.1
Fawcett, J.2
Tsui, B.T.3
Bennett, R.G.4
Duckworth, W.C.5
-
19
-
-
38349147618
-
Environmental enrichment counteracts Alzheimer's neurovascular dysfunction in TgCRND8 mice
-
Herring A., Yasin H., Ambree O., Sachser N., Paulus W., and Keyvani K. Environmental enrichment counteracts Alzheimer's neurovascular dysfunction in TgCRND8 mice. Brain Pathol. 18 (2008) 32-39
-
(2008)
Brain Pathol.
, vol.18
, pp. 32-39
-
-
Herring, A.1
Yasin, H.2
Ambree, O.3
Sachser, N.4
Paulus, W.5
Keyvani, K.6
-
20
-
-
54049094343
-
Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease
-
Miller M.C., Tavares R., Johanson C.E., Hovanesian V., Donahue J.E., Gonzalez L., Silverberg G.D., and Stopa E.G. Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease. Brain Res. 1230 (2008) 273-280
-
(2008)
Brain Res.
, vol.1230
, pp. 273-280
-
-
Miller, M.C.1
Tavares, R.2
Johanson, C.E.3
Hovanesian, V.4
Donahue, J.E.5
Gonzalez, L.6
Silverberg, G.D.7
Stopa, E.G.8
-
21
-
-
41149149615
-
Abeta-degrading enzymes in Alzheimer's disease
-
Miners J.S., Baig S., Palmer J., Palmer L.E., Kehoe P.G., and Love S. Abeta-degrading enzymes in Alzheimer's disease. Brain Pathol. 18 (2008) 240-252
-
(2008)
Brain Pathol.
, vol.18
, pp. 240-252
-
-
Miners, J.S.1
Baig, S.2
Palmer, J.3
Palmer, L.E.4
Kehoe, P.G.5
Love, S.6
-
22
-
-
0036746143
-
Pro-inflammatory effect of freshly solubilized beta-amyloid peptides in the brain
-
Paris D., Townsend K.P., Obregon D.F., Humphrey J., and Mullan M. Pro-inflammatory effect of freshly solubilized beta-amyloid peptides in the brain. Prostaglandins Other Lipid Mediat. 70 (2002) 1-12
-
(2002)
Prostaglandins Other Lipid Mediat.
, vol.70
, pp. 1-12
-
-
Paris, D.1
Townsend, K.P.2
Obregon, D.F.3
Humphrey, J.4
Mullan, M.5
-
23
-
-
12644270205
-
Immunological markers of disease progression in patients infected with the human immunodeficiency virus
-
Pascale J.M., Isaacs M.D., Contreras P., Gomez B., Lozano L., Austin E., De Martin M.C., Gregory R.L., McLaughlin G.L., and Amador A. Immunological markers of disease progression in patients infected with the human immunodeficiency virus. Clin. Diagn. Lab. Immunol. 4 (1997) 474-477
-
(1997)
Clin. Diagn. Lab. Immunol.
, vol.4
, pp. 474-477
-
-
Pascale, J.M.1
Isaacs, M.D.2
Contreras, P.3
Gomez, B.4
Lozano, L.5
Austin, E.6
De Martin, M.C.7
Gregory, R.L.8
McLaughlin, G.L.9
Amador, A.10
-
24
-
-
67649099340
-
HIV regulation of amyloid beta production
-
Pulliam L. HIV regulation of amyloid beta production. J. Neuroimmune Pharmacol. 4 (2009) 213-217
-
(2009)
J. Neuroimmune Pharmacol.
, vol.4
, pp. 213-217
-
-
Pulliam, L.1
-
25
-
-
35648986681
-
Amyloid-beta(1-42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfate
-
Rangachari V., Moore B.D., Reed D.K., Sonoda L.K., Bridges A.W., Conboy E., Hartigan D., and Rosenberry T.L. Amyloid-beta(1-42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfate. Biochemistry 46 (2007) 12451-12462
-
(2007)
Biochemistry
, vol.46
, pp. 12451-12462
-
-
Rangachari, V.1
Moore, B.D.2
Reed, D.K.3
Sonoda, L.K.4
Bridges, A.W.5
Conboy, E.6
Hartigan, D.7
Rosenberry, T.L.8
-
26
-
-
15744363144
-
HIV-1 Tat inhibits neprilysin and elevates amyloid beta
-
Rempel H.C., and Pulliam L. HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS 19 (2005) 127-135
-
(2005)
AIDS
, vol.19
, pp. 127-135
-
-
Rempel, H.C.1
Pulliam, L.2
-
27
-
-
34547380204
-
Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
-
Rogers J., Mastroeni D., Leonard B., Joyce J., and Grover A. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?. Int. Rev. Neurobiol. 82 (2007) 235-246
-
(2007)
Int. Rev. Neurobiol.
, vol.82
, pp. 235-246
-
-
Rogers, J.1
Mastroeni, D.2
Leonard, B.3
Joyce, J.4
Grover, A.5
-
28
-
-
34948888151
-
Clearance of amyloid-beta by circulating lipoprotein receptors
-
Sagare A., Deane R., Bell R.D., Johnson B., Hamm K., Pendu R., Marky A., Lenting P.J., Wu Z., Zarcone T., Goate A., Mayo K., Perlmutter D., Coma M., Zhong Z., and Zlokovic B.V. Clearance of amyloid-beta by circulating lipoprotein receptors. Nat. Med. 13 (2007) 1029-1031
-
(2007)
Nat. Med.
, vol.13
, pp. 1029-1031
-
-
Sagare, A.1
Deane, R.2
Bell, R.D.3
Johnson, B.4
Hamm, K.5
Pendu, R.6
Marky, A.7
Lenting, P.J.8
Wu, Z.9
Zarcone, T.10
Goate, A.11
Mayo, K.12
Perlmutter, D.13
Coma, M.14
Zhong, Z.15
Zlokovic, B.V.16
-
29
-
-
0029882671
-
RAGE: a novel cellular receptor for advanced glycation end products
-
Schmidt A.M., Hori O., Cao R., Yan S.D., Brett J., Wautier J.L., Ogawa S., Kuwabara K., Matsumoto M., and Stern D. RAGE: a novel cellular receptor for advanced glycation end products. Diabetes 45 Suppl. 3 (1996) S77-80
-
(1996)
Diabetes
, vol.45
, Issue.SUPPL. 3
-
-
Schmidt, A.M.1
Hori, O.2
Cao, R.3
Yan, S.D.4
Brett, J.5
Wautier, J.L.6
Ogawa, S.7
Kuwabara, K.8
Matsumoto, M.9
Stern, D.10
-
30
-
-
0026646605
-
Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids
-
Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., et al. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 359 (1992) 325-327
-
(1992)
Nature
, vol.359
, pp. 325-327
-
-
Seubert, P.1
Vigo-Pelfrey, C.2
Esch, F.3
Lee, M.4
Dovey, H.5
Davis, D.6
Sinha, S.7
Schlossmacher, M.8
Whaley, J.9
Swindlehurst, C.10
-
31
-
-
65249130676
-
A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma
-
Sondergaard T.E., Pedersen P.T., Andersen T.L., Soe K., Lund T., Ostergaard B., Garnero P., Delaisse J.M., and Plesner T. A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma. Hematol. Oncol. 27 (2009) 17-22
-
(2009)
Hematol. Oncol.
, vol.27
, pp. 17-22
-
-
Sondergaard, T.E.1
Pedersen, P.T.2
Andersen, T.L.3
Soe, K.4
Lund, T.5
Ostergaard, B.6
Garnero, P.7
Delaisse, J.M.8
Plesner, T.9
-
32
-
-
17644380598
-
Mechanisms of the blood-brain barrier disruption in HIV-1 infection
-
Toborek M., Lee Y.W., Flora G., Pu H., Andras I.E., Wylegala E., Hennig B., and Nath A. Mechanisms of the blood-brain barrier disruption in HIV-1 infection. Cell. Mol. Neurobiol. 25 (2005) 181-199
-
(2005)
Cell. Mol. Neurobiol.
, vol.25
, pp. 181-199
-
-
Toborek, M.1
Lee, Y.W.2
Flora, G.3
Pu, H.4
Andras, I.E.5
Wylegala, E.6
Hennig, B.7
Nath, A.8
-
33
-
-
0242322487
-
Modulation of the LDL receptor and LRP levels by HIV protease inhibitors
-
Tran H., Robinson S., Mikhailenko I., and Strickland D.K. Modulation of the LDL receptor and LRP levels by HIV protease inhibitors. J. Lipid Res. 44 (2003) 1859-1869
-
(2003)
J. Lipid Res.
, vol.44
, pp. 1859-1869
-
-
Tran, H.1
Robinson, S.2
Mikhailenko, I.3
Strickland, D.K.4
-
34
-
-
4644321592
-
Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging With HIV-1 Cohort
-
Valcour V., Shikuma C., Shiramizu B., Watters M., Poff P., Selnes O., Holck P., Grove J., and Sacktor N. Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging With HIV-1 Cohort. Neurology 63 (2004) 822-827
-
(2004)
Neurology
, vol.63
, pp. 822-827
-
-
Valcour, V.1
Shikuma, C.2
Shiramizu, B.3
Watters, M.4
Poff, P.5
Selnes, O.6
Holck, P.7
Grove, J.8
Sacktor, N.9
-
35
-
-
27744460321
-
Blood-Brain barrier-specific properties of a human adult brain endothelial cell line
-
Weksler B.B., Subileau E.A., Perriere N., Charneau P., Holloway K., Leveque M., Tricoire-Leignel H., Nicotra A., Bourdoulous S., Turowski P., Male D.K., Roux F., Greenwood J., Romero I.A., and Couraud P.O. Blood-Brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 19 (2005) 1872-1874
-
(2005)
FASEB J.
, vol.19
, pp. 1872-1874
-
-
Weksler, B.B.1
Subileau, E.A.2
Perriere, N.3
Charneau, P.4
Holloway, K.5
Leveque, M.6
Tricoire-Leignel, H.7
Nicotra, A.8
Bourdoulous, S.9
Turowski, P.10
Male, D.K.11
Roux, F.12
Greenwood, J.13
Romero, I.A.14
Couraud, P.O.15
-
36
-
-
67649085899
-
The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era
-
Xu J., and Ikezu T. The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era. J. Neuroimmune Pharmacol 4 (2009) 200-212
-
(2009)
J. Neuroimmune Pharmacol
, vol.4
, pp. 200-212
-
-
Xu, J.1
Ikezu, T.2
-
37
-
-
58049199498
-
The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid beta peptides in an in vitro model of the blood-brain barrier cells
-
Yamada K., Hashimoto T., Yabuki C., Nagae Y., Tachikawa M., Strickland D.K., Liu Q., Bu G., Basak J.M., Holtzman D.M., Ohtsuki S., Terasaki T., and Iwatsubo T. The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid beta peptides in an in vitro model of the blood-brain barrier cells. J. Biol. Chem. 283 (2008) 34554-34562
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 34554-34562
-
-
Yamada, K.1
Hashimoto, T.2
Yabuki, C.3
Nagae, Y.4
Tachikawa, M.5
Strickland, D.K.6
Liu, Q.7
Bu, G.8
Basak, J.M.9
Holtzman, D.M.10
Ohtsuki, S.11
Terasaki, T.12
Iwatsubo, T.13
-
38
-
-
0013615899
-
RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease
-
Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., and Schmidt A.M. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382 (1996) 685-691
-
(1996)
Nature
, vol.382
, pp. 685-691
-
-
Yan, S.D.1
Chen, X.2
Fu, J.3
Chen, M.4
Zhu, H.5
Roher, A.6
Slattery, T.7
Zhao, L.8
Nagashima, M.9
Morser, J.10
Migheli, A.11
Nawroth, P.12
Stern, D.13
Schmidt, A.M.14
-
39
-
-
0001358519
-
Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis
-
Yan S.D., Zhu H., Zhu A., Golabek A., Du H., Roher A., Yu J., Soto C., Schmidt A.M., Stern D., and Kindy M. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat. Med. 6 (2000) 643-651
-
(2000)
Nat. Med.
, vol.6
, pp. 643-651
-
-
Yan, S.D.1
Zhu, H.2
Zhu, A.3
Golabek, A.4
Du, H.5
Roher, A.6
Yu, J.7
Soto, C.8
Schmidt, A.M.9
Stern, D.10
Kindy, M.11
-
40
-
-
46749099351
-
New therapeutic targets in the neurovascular pathway in Alzheimer's disease
-
Zlokovic B.V. New therapeutic targets in the neurovascular pathway in Alzheimer's disease. Neurotherapeutics 5 (2008) 409-414
-
(2008)
Neurotherapeutics
, vol.5
, pp. 409-414
-
-
Zlokovic, B.V.1
-
41
-
-
0033943469
-
Clearance of amyloid beta-peptide from brain: transport or metabolism?
-
Zlokovic B.V., Yamada S., Holtzman D., Ghiso J., and Frangione B. Clearance of amyloid beta-peptide from brain: transport or metabolism?. Nat. Med. 6 (2000) 718-719
-
(2000)
Nat. Med.
, vol.6
, pp. 718-719
-
-
Zlokovic, B.V.1
Yamada, S.2
Holtzman, D.3
Ghiso, J.4
Frangione, B.5
|